https://www.selleckchem.com/pr....oducts/z-vad(oh)-fmk
Recommended hypoglycemia treatment in adults with T1D consists of 15g of rapid absorption carbohydrates. We aimed to evaluate the response to fewer carbohydrates for treating hypoglycemia in patients with T1D on insulin pumps with predictive suspension technology (PLGS). T1D patients on insulin pumps with PLGS were randomized to receive 10 or 15g of sucrose per hypoglycemia for two weeks (S10 and S15 groups, respectively) when capillary blood glucose (BG) was 70mg/dL, with crossover after two weeks. Evolution of capillary BG,